Global Polypill Trials for Cardiovascular Disease Prevention

The chapter delves into the results of a study on a polypill for cardiovascular disease prevention in rural Iran, showcasing a 4% absolute risk reduction in major cardiovascular events among participants. It underscores the necessity of conducting diverse population studies worldwide to enhance the applicability of clinical trial findings, especially in resource-limited settings.